Telavancin: A Novel Lipoglycopeptide - Saravolatz, Louis D.; Stein, Gary E.; Johnson, Leonard B. (Clinical infectious diseases, 2009)
Keywords: Aminoglycosides - adverse effects; Aminoglycosides - pharmacokinetics; Aminoglycosides - pharmacology; Aminoglycosides - therapeutic use; Anti-Bacterial Agents - pharmacology; Antibacterial agents; Antibiotics; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antimicrobials; Biological and medical sciences; Cell membranes; Chemistry, Pharmaceutical; Clinical trials; Dosage; Glycopeptides; Humans; Infections; Infectious diseases; Medical sciences; Medical treatment; Methicillin resistant staphylococcus aureus; Peptides; Pharmacokinetics; Pharmacology. Drug treatments; REVIEWS OF ANTI-INFECTIVE AGENTS; Skin; Staphylococcus aureus; Staphylococcus infections; Infection; Telavancin; Antibiotic; Antibacterial agent